[1]李 瑶,刘 力,谭福雄,等.鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化疗效Meta分析*[J].陕西中医,2020,(9):1329-1334.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
　LI Yao,LIU Li,TAN Fuxiong,et al.Efficacy of Biejia Jianwan combined with entecavir for chronic hepatitis B cirrhosis:a Meta-analysis[J].,2020,(9):1329-1334.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
点击复制

鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化疗效Meta分析*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年9期
页码:
1329-1334
栏目:
Meta分析
出版日期:
2020-09-05

文章信息/Info

Title:
Efficacy of Biejia Jianwan combined with entecavir for chronic hepatitis B cirrhosis:a Meta-analysis
作者:
李 瑶1; 刘 力1; 谭福雄1; 夏国珍1; 王小锋2
1.陕西中医药大学(咸阳712046); 2.陕西中医药大学附属医院(咸阳 712021)
Author(s):
LI Yao; LIU Li; TAN Fuxiong; et al.
Shaanxi University of Chinese Medicine(Xianyang 712046)
关键词:
鳖甲煎丸;  恩替卡韦;  乙型肝炎肝硬化;  Meta分析;  系统分析
Keywords:
Biejia Jianwan;  Entecavir;  Chronic hepatitis B cirrhosis;  Meta analysis;  Systematic analysis
分类号:
R575.2
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.043
文献标志码:
A
摘要:
目的:评价鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化的临床疗效。方法:检索国内外常用中英文数据库,搜集有关鳖甲煎丸治疗乙型肝炎肝硬化的临床随机对照试验(RCT)。两位评价员独立筛取文献、纳入基本信息,并对纳入研究进行质量评价和偏倚风险评估后,用 RevMan 5.3 软件进行 Meta 分析。结果:本研究纳入13个 RCT,总计1068例患者,其中5个为高质量研究,其余8个为低质量。Meta分析结果显示,鳖甲煎丸联合治疗组的血清肝功能即AIT、AST、ALB的改善显著优于单用恩替卡韦组。鳖甲煎丸联合治疗组的血清肝纤维化水平显著低于单用恩替卡韦组。鳖甲煎丸联合治疗组不增加药物的不良反应。结论:与单用恩替卡韦相比,鳖甲煎丸联合治疗乙型肝炎肝硬化疗效较好,可显著改善乙型肝炎肝硬化患者血清肝功能、降低肝纤维化四项水平,且无显著不良反应。但受纳入RCT数量及质量的影响,上述结论尚需更多高质量的RCT予以验证。
Abstract:
Objective:To systematically review the clinical efficacy of treatment with Biejia Jianwan combined with entecavir chronic hepatitis B cirrhosis.Methods:The common Chinese and English databases were searched by computer,and the RCT of Biejia Jianwan in the treatment of chronic hepatitis B cirrhosis was collected.The two evaluators independently screened the literature and included the basic information.After the quality evaluation and bias risk assessment of the included study,used Revman 5.3 software for Meta analysis.Results: 13 RCTs were included in the study,a total of 1068 patients,5 of which were high-quality studies,and the other 8 were low-quality studies.The results of Meta analysis showed that the improvement of serum liver function(AIT,AST,ALB)in Biejia Jianwan combined treatment group was significantly better than that of entecavir alone.The level of serum liver fibrosis in the combined treatment group was significantly lower than that of entecavir alone.The adverse reactions of Biejia Jianwan combined therapy group did not increase.Conclusion:Compared with entecavir alone,combined with Biejia Jianwan has better effect in the treatment of chronic hepatitis B cirrhosis.It can significantly improve the serum liver function and reduce the four levels of liver fibrosis in patients with chronic hepatitis B cirrhosis,and has no significant adverse reactions.However,affected by the quantity and quality of RCTs,the above conclusions need to be verified by more high-quality RCTs.

参考文献/References:

[1] Ott JJ,Stevens GA,Groeger J,et al.Global epidemiology of hepatitis B virus infection:new estimetas of age- specific HBsAg seroprevalence and endemicity[J].Vaccine,2012,30(12):2212-2219.
[2] 王贵强,王福生,庄 辉,等.慢性乙型肝炎防治指南[J].临床肝胆病杂志,2019,35(12):2648-2669.
[3] Zeng FF,Guo P,Huang Y,et al.Epidemiology of hepatitis B virus infection:results from a community-based study of 0.15 million residents in south China[J].Sci Rep,2016,33(6):361-368.
[4] 赵治凤,樊晋宇,张光谋.1400例肝硬化患者流行病学分析[J].中国卫生检验杂志,2016,26(3):414-415,418.
[5] 徐列明,刘 平,沈锡中,等.肝纤维化中西医结合诊疗指南[J].中国中西医结合杂志,2019,39(11):1286-1295.
[6] Jadad AR,Moore RA,Carroll D.Assessing the quality of reports of randomized clinical trials:is blinding necessary[J].Control Clin Trials,1996,17(1):1-12.
[7] Higgins JP,Green S.Cochrane handbook for systematic reviews of interventions[J].Available,2018,33(1):105-109.
[8] 何 梅,李 芳,朱 琳.鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化30例[J].中西医结合肝病杂志,2009,19(1):53-54.
[9] 关 华,刘玉萍,李明非,等.鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化代偿期的效果观察[J].中药药理与临床,2017,33(1):194-196.
[10] 吴玉叶.鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化疗效观察[J].中国现代药物应用,2016,10(4):137-138.
[11] 吴秀丽,于建云.鳖甲煎丸联合恩替卡韦对乙型肝炎肝硬化代偿期患者的影响[J].河南医学研究,2019,28(12):2239-2240.
[12] 徐玉玲,罗宏伟,丁 沛.鳖甲煎丸对慢性乙型肝炎早期肝硬化患者肿瘤坏死因子-α和基质金属蛋白酶-2的影响[J].世界中医药,2017,12(9):2077-2079,2083.
[13] 徐礼通,杨 平.鳖甲煎丸对慢性乙型肝炎早期肝硬化患者血清肿瘤坏死因子-α和白细胞介素-6的影响[J].中国中西医结合消化杂志,2014,22(1):13-15.
[14] 李恒飞,鄢灯莹,徐 建,等.鳖甲煎丸治疗肝炎肝硬化的临床效果[J].中国当代医药,2018,25(27):16-19.
[15] 李爱民,刘文涛.鳖甲煎丸联合恩替卡韦治疗乙型肝炎肝硬化的临床疗效观察[J].湖北中医杂志,2017,39(5):16-18.
[16] 汪慧兰.恩替卡韦联合鳖甲煎丸治疗乙型肝炎肝硬化失代偿临床疗效[J].临床医药文献电子杂志,2019,6(38):62.
[17] 王 捷.恩替卡韦联合鳖甲煎丸治疗代偿性乙型肝炎肝硬化58例[J].国医论坛,2018,33(2):49-50.
[18] 许世申.鳖甲煎丸联合恩替卡韦胶囊治疗乙型肝炎肝硬化肝功能代偿期的效果观察[J].临床医学工程,2019,26(1):83-84.
[19] 雷 君,许绿叶,王 莹.恩替卡韦联合鳖甲煎丸治疗乙型肝炎肝硬化45例[J].中西医结合肝病杂志,2019,29(1):77-78.
[20] 黄 冠,罗霄霄.鳖甲煎丸联合恩替卡韦治疗乙肝后肝硬化疗效观察[J].慢性病学杂志,2019,20(2):279-281,284.

相似文献/References:

[1]田水林,施 琳,施卫兵△.逍遥散联合恩替卡韦治疗肝郁脾虚型慢性乙型肝炎疗效研究*[J].陕西中医,2020,(6):754.[doi:DOI:10.3969/j.issn.10007369.2020.06.015]
　TIAN Shuilin,SHI Lin,SHI Weibing..Study on effect of Xiaoyao powder combined with entecavir on patients with chronic hepatitis B of Ganyu Pixu type[J].,2020,(9):754.[doi:DOI:10.3969/j.issn.10007369.2020.06.015]

备注/Memo

备注/Memo:
*国家自然科学基金资助项目(81774132);陕西中医药大学科研基金资助项目(2015K04-21)
更新日期/Last Update: 2020-09-08